Clinical Trials
2 trialsNCT05297552 2024-02-20
A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer
RemeGen Co., Ltd.
Phase 2 Unknown
NCT06074484 2023-10-10
A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown